Nuveen
ANGO icon

Nuveen’s AngioDynamics ANGO Stock Holding History

Nuveen’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Sell
1,199,358
-16,807
-1% -$191K ﹤0.01% 1417
2026
Q1 		$13.8M Sell
1,216,165
-78,907
-6% -$855K ﹤0.01% 1364
2025
Q4 		$16.6M Buy
1,295,072
+373,110
+40% +$4.61M ﹤0.01% 1253
2025
Q3 		$10.3M Sell
921,962
-126,680
-12% -$1.22M ﹤0.01% 1533
2025
Q2 		$10.4M Sell
1,048,642
-101,876
-9% -$997K ﹤0.01% 1481
2025
Q1 		$10.8M Sell
1,150,518
-145,848
-11% -$1.53M ﹤0.01% 1509
2024
Q4 		$11.9M Buy
1,296,366
+353,070
+37% +$2.6M ﹤0.01% 1507
2024
Q3 		$7.34M Buy
943,296
+46,665
+5% +$337K ﹤0.01% 1792
2024
Q2 		$5.42M Buy
896,631
+520,881
+139% +$3.21M ﹤0.01% 1908
2024
Q1 		$2.21M Sell
375,750
-54,679
-13% -$325K ﹤0.01% 2359
2023
Q4 		$3.37M Buy
430,429
+73,397
+21% +$509K ﹤0.01% 2160
2023
Q3 		$2.61M Sell
357,032
-150,221
-30% -$1.25M ﹤0.01% 2186
2023
Q2 		$5.29M Buy
507,253
+78,438
+18% +$755K ﹤0.01% 1886
2023
Q1 		$4.43M Buy
428,815
+111,340
+35% +$1.43M ﹤0.01% 1964
2022
Q4 		$4.37M Buy
317,475
+55,371
+21% +$770K ﹤0.01% 1992
2022
Q3 		$5.36M Sell
262,104
-4,670
-2% -$103K ﹤0.01% 1862
2022
Q2 		$5.16M Sell
266,774
-47,050
-15% -$964K ﹤0.01% 1911
2022
Q1 		$7.23M Sell
313,824
-72,700
-19% -$1.65M ﹤0.01% 1844
2021
Q4 		$10.7M Sell
386,524
-69,230
-15% -$1.91M ﹤0.01% 1648
2021
Q3 		$11.8M Sell
455,754
-56,165
-11% -$1.5M ﹤0.01% 1662
2021
Q2 		$13.9M Sell
511,919
-48,025
-9% -$1.17M ﹤0.01% 1645
2021
Q1 		$13.1M Sell
559,944
-3,996
-0.7% -$80.8K ﹤0.01% 1623
2020
Q4 		$8.64M Sell
563,940
-28,749
-5% -$365K ﹤0.01% 1803
2020
Q3 		$7.15M Buy
592,689
+14,192
+2% +$135K ﹤0.01% 1728
2020
Q2 		$5.88M Buy
578,497
+10,328
+2% +$106K ﹤0.01% 1809
2020
Q1 		$5.93M Buy
568,169
+26,618
+5% +$334K ﹤0.01% 1611
2019
Q4 		$8.67M Buy
541,551
+278,403
+106% +$4.25M ﹤0.01% 1668
2019
Q3 		$4.85M Buy
263,148
+16,048
+6% +$314K ﹤0.01% 1972
2019
Q2 		$4.86M Buy
+247,100
New +$5.03M ﹤0.01% 2012

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen's ANGO Position: Q2 2026 in Review

Nuveen reduced its AngioDynamics (ANGO) stake by 1.4% in Q2 2026, selling an estimated $191K and leaving 1,199,358 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Nuveen first reported a position in ANGO in Q2 2019 and has held it in 29 quarters since. The position peaked at $16.6M in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Nuveen held 1,199,358 shares of AngioDynamics worth $15.6M as of Q2 2026.
  • Nuveen sold 16,807 AngioDynamics shares in Q2 2026, an estimated $191K.
  • AngioDynamics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1417 holding.
  • Nuveen first reported a position in AngioDynamics in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's AngioDynamics position peaked at $16.6M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.